Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy
- PMID: 20525370
- PMCID: PMC2898696
- DOI: 10.1186/1471-2407-10-259
Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy
Abstract
Background: Cervical cancer represents an important global public health problem. It is the 2nd most common cancer among women worldwide. Human papillomavirus (HPV) infection is now well-established as a necessary cause of invasive cervical cancer (ICC) development. Only a few studies on HPV prevalence and type-specific distribution in ICC have been conducted in Italy.
Aim: To describe the prevalence of HPV and the HPV type-specific distribution in ICC cases identified in Rome, Italy.
Methods: 140 paraffin embedded tissue blocks of primary ICC diagnosed between 2001 and 2006 were identified at the Regina Elena Cancer Institute in Rome (Italy). HPV was detected through amplification of HPV DNA using SPF-10 HPV broad-spectrum primers followed by DEIA and then genotyping by LiPA25 (version 1).
Results: 134 cases were considered suitable for HPV DNA detection after histological evaluation; and overall, 90.3% (121/134) HPV prevalence was detected. 111 cases had a single HPV type, 4 cases had an uncharacterized type (HPVX) and 6 cases had multiple HPV infections. The five most common single HPV types among positive cases were: HPV16 (71/121; 58.7%), HPV18 (12/121; 9.9%), HPV31, HPV45 and HPV58 (5/121; 4.1% each). 2 (1.5%) of the single infections and 2 (1.5%) of the multiple infections contained low risk types. Statistically significant differences in the relative contribution of HPV18 were found when comparing squamous cell carcinomas with adenocarcinomas.
Conclusions: HPV16 and HPV18 accounted for almost 70% of all the HPV positive ICC cases. The study provides baseline information for further evaluation on the impact of recently introduced HPV vaccines in Italy.
Figures
Similar articles
-
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15. Lancet Oncol. 2010. PMID: 20952254
-
Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.Int J Cancer. 2014 Mar 15;134(6):1389-98. doi: 10.1002/ijc.28425. Epub 2013 Nov 14. Int J Cancer. 2014. PMID: 23929250
-
Human papillomavirus types in invasive cervical cancer specimens from Turkey.Int J Gynecol Pathol. 2009 Nov;28(6):541-8. doi: 10.1097/PGP.0b013e3181aaba0d. Int J Gynecol Pathol. 2009. PMID: 19851201
-
Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.Lancet. 2024 Aug 3;404(10451):435-444. doi: 10.1016/S0140-6736(24)01097-3. Lancet. 2024. PMID: 39097395
-
HPV prevalence and genotyping in the cervix of Chinese women.Front Med China. 2010 Sep;4(3):259-63. doi: 10.1007/s11684-010-0095-5. Epub 2010 Sep 9. Front Med China. 2010. PMID: 21191828 Review.
Cited by
-
Human papillomavirus infection and follow-up on positive results in 7222 female samples obtained from 2016 to 2019 in Hefei, China.PeerJ. 2020 Oct 20;8:e10179. doi: 10.7717/peerj.10179. eCollection 2020. PeerJ. 2020. PMID: 33150081 Free PMC article.
-
Polymerase chain reaction and deoxyribonucleic acid-sequencing based study on distribution of human papillomavirus 16/18 among histopathological types of cervical intra-epithelial neoplasia and primary invasive cervical carcinoma: A scenario in North Bengal, India.J Midlife Health. 2014 Jan;5(1):14-22. doi: 10.4103/0976-7800.127786. J Midlife Health. 2014. PMID: 24672201 Free PMC article.
-
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies.Infect Agent Cancer. 2012 Oct 12;7(1):26. doi: 10.1186/1750-9378-7-26. Infect Agent Cancer. 2012. PMID: 23110797 Free PMC article.
-
A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.BMC Infect Dis. 2013 Feb 7;13:74. doi: 10.1186/1471-2334-13-74. BMC Infect Dis. 2013. PMID: 23390953 Free PMC article.
-
Distribution of HPV Genotypes and Involvement of Risk Factors in Cervical Lesions and Invasive Cervical Cancer: A Study in an Indian Population.Int J Mol Cell Med. 2014 Spring;3(2):61-73. Int J Mol Cell Med. 2014. PMID: 25035855 Free PMC article.
References
-
- Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002 cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press; 2004. IARC Cancer Base No.5 version 2.0.
-
- Castellsagué X, de Sanjosé S, Aguado T, Louie KS, Bruni L, Muñoz J, Diaz M, Irwin K, Gacic M, Beauvais O, Albero G, Ferrer E, Byrne S, Bosch FX. HPV and Cervical Cancer in the World. 2007 Report. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) Vaccine. 2007;25(S3):C110.
-
- Muñoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, Gonzalez LC, Kaldor JM, Guerrero E, Lorincz A, Santamaria M, Alonso De Ruiz P, Aristizabal N, Shah K. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52:743–749. doi: 10.1002/ijc.2910520513. - DOI - PubMed
-
- Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796–802. doi: 10.1093/jnci/87.11.796. - DOI - PubMed